Synta to Present at the Deutsche Bank 2012 dbAccess BioFEST

Synta to Present at the Deutsche Bank 2012 dbAccess BioFEST

<0> Synta Pharmaceuticals Corp.George Farmer, 781-541-7125 </0>

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3 at 10:45 a.m. (EST) in Boston.

A live audio and replay of the presentation will be available on the "Investors" section of the Company's website, .

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit .

Suggested Articles

Myovant’s uterine fibroid drug reduced blood loss in nearly three-quarters of patients, trouncing placebo in the second of two phase 3 studies.

The cystic fibrosis biotech unveiled Belous’ appointment alongside news of the promotion of Geoff Gilmartin to the CMO position.

The series C round is the latest in a series of boosts for Frequency’s attempts to tackle hearing loss through the activation of progenitor cells.